Literature DB >> 11179971

Hydrolysis of glycine-containing elastin pentapeptides by LasA, a metalloelastase from Pseudomonas aeruginosa.

S Vessillier1, F Delolme, J Bernillon, J Saulnier, J Wallach.   

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen that causes severe infections in vulnerable hosts. It may produce various virulence factors including proteases. Among them, LasA possesses both elastolytic and staphylolytic (hydrolysis of pentaglycine cross-links in the cell wall peptidoglycan) activities. To understand if its elastolytic activity results from a preference for glycine-rich substrates, we studied its ability to hydrolyse the 65 pentapeptides of human tropoelastin containing at least three glycines. As demonstrated by capillary electrophoresis (CE), 22 of these peptides were hydrolysed by LasA, generally at a single peptide bond and the catalytic ratio kcat/KM was determined for most of them. The highest value was obtained for LGGGA, 59 +/- 9 min(-1) x mmol(-1) x L. The specificity of hydrolysis was elucidated by CE, liquid secondary ion mass spectrometry and, in some cases, collision activated dissociation-mass analysis of ion kinetic energy. The preferred cleavage sites are GG and GA peptide bonds, the sequence GG(cleavage site)A being especially sensitive to hydrolysis. Both positions P2 and P'2 must be occupied for hydrolysis and the presence of an amino acid in P3 (but not in P'3) significantly increases the catalytic ratio. Considering these results, about 30 GGX sequences (X: G, A or Y) of human tropoelastin could be susceptible to LasA elastolysis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179971     DOI: 10.1046/j.1432-1327.2001.01967.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Elastolytic mechanism of a novel M23 metalloprotease pseudoalterin from deep-sea Pseudoalteromonas sp. CF6-2: cleaving not only glycyl bonds in the hydrophobic regions but also peptide bonds in the hydrophilic regions involved in cross-linking.

Authors:  Hui-Lin Zhao; Xiu-Lan Chen; Bin-Bin Xie; Ming-Yang Zhou; Xiang Gao; Xi-Ying Zhang; Bai-Cheng Zhou; Anthony S Weiss; Yu-Zhong Zhang
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

2.  Pseudomonas aeruginosa LasA protease in treatment of experimental staphylococcal keratitis.

Authors:  Irina S Barequet; Guy J Ben Simon; Mary Safrin; Dennis E Ohman; Efrat Kessler
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

3.  Crystal Structure of Human Leukocyte Cell-derived Chemotaxin 2 (LECT2) Reveals a Mechanistic Basis of Functional Evolution in a Mammalian Protein with an M23 Metalloendopeptidase Fold.

Authors:  Hai Zheng; Takuya Miyakawa; Yoriko Sawano; Atsuko Asano; Akinori Okumura; Satoshi Yamagoe; Masaru Tanokura
Journal:  J Biol Chem       Date:  2016-06-22       Impact factor: 5.157

4.  Similar active sites in lysostaphins and D-Ala-D-Ala metallopeptidases.

Authors:  Matthias Bochtler; Sergey G Odintsov; Malgorzata Marcyjaniak; Izabela Sabala
Journal:  Protein Sci       Date:  2004-04       Impact factor: 6.725

5.  Structural Characterization of EnpA D,L-Endopeptidase from Enterococcus faecalis Prophage Provides Insights into Substrate Specificity of M23 Peptidases.

Authors:  Piotr Henryk Małecki; Paweł Mitkowski; Elżbieta Jagielska; Karolina Trochimiak; Stéphane Mesnage; Izabela Sabała
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

Review 6.  Peptidoglycan hydrolases-potential weapons against Staphylococcus aureus.

Authors:  Piotr Szweda; Marta Schielmann; Roman Kotlowski; Grzegorz Gorczyca; Magdalena Zalewska; Slawomir Milewski
Journal:  Appl Microbiol Biotechnol       Date:  2012-10-18       Impact factor: 4.813

7.  Evaluation of a FRET-peptide substrate to predict virulence in Pseudomonas aeruginosa.

Authors:  Wendy E Kaman; Nora El Arkoubi-El Arkoubi; Sanne Roffel; Hubert P Endtz; Alex van Belkum; Floris J Bikker; John P Hays
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.